Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'23
Sep'23
Jun'23
Mar'23
Dec'22
Sep'22
Jun'22
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Raw Material Cost
0.20
0.20
0.20
0.20
0.19
0.18
0.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
5.54
6.41
7.61
7.89
7.31
7.64
7.47
Other Expenses
1.34
2.45
2.63
2.66
2.52
2.35
1.98
Total Expenditure (Excl Depreciation)
19.10
31.12
34.13
34.65
32.68
31.37
27.41
Operating Profit (PBDIT) excl Other Income
-19.099999999999998
-31.099999999999998
-34.1
-34.7
-32.7
-31.400000000000002
-27.400000000000002
Other Income
2.24
2.36
2.22
1.71
1.12
0.64
0.34
Operating Profit (PBDIT)
-16.66
-28.56
-31.72
-32.74
-31.37
-30.55
-26.90
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-0.20
-1.97
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-0.20
-0.20
-0.20
-0.20
-0.19
-0.18
-0.17
Depreciation
0.20
0.20
0.20
0.20
0.19
0.18
0.17
Profit Before Tax
-17.06
-30.73
-31.92
-32.94
-31.56
-30.74
-27.07
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-17.06
-30.73
-31.92
-32.94
-31.56
-30.74
-27.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-17.06
-30.73
-31.92
-32.94
-31.56
-30.74
-27.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-17.06
-30.73
-31.92
-32.94
-31.56
-30.74
-27.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
159.33
172.42
197.62
222.76
223.47
248.34
273.73
Earnings per share (EPS)
-0.36
-0.65
-0.68
-0.73
-0.71
-0.7
-0.62
Diluted Earnings per share
-0.36
-0.65
-0.68
-0.73
-0.71
-0.7
-0.62
Operating Profit Margin (Excl OI)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2023 is 0.00% vs 0.00% in Sep 2023
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2023 is 44.30% vs 3.76% in Sep 2023
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2023 is 38.83% vs 8.85% in Sep 2023
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2023 has improved from Sep 2023
Compare Quarterly Results Of Kinnate Biopharma, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
0.00
18.84
-18.84
-100.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.00
18.84
-18.84
-100.00%
Raw Material Cost
0.20
1.68
-1.48
-88.10%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
13.00
-13.00
-100.00%
Selling and Distribution Expenses
5.54
18.13
-12.59
-69.44%
Other Expenses
1.34
1.71
-0.37
-21.64%
Total Expenditure (Excl Depreciation)
19.10
49.90
-30.80
-61.72%
Operating Profit (PBDIT) excl Other Income
-19.10
-31.06
11.96
38.51%
Other Income
2.24
1.27
0.97
76.38%
Operating Profit (PBDIT)
-16.66
-28.95
12.29
42.45%
Interest
0.00
13.00
-13.00
-100.00%
Exceptional Items
-0.20
-13.09
12.89
98.47%
Gross Profit (PBDT)
-0.20
17.16
-17.36
-101.17%
Depreciation
0.20
0.84
-0.64
-76.19%
Profit Before Tax
-17.06
-55.87
38.81
69.46%
Tax
0.00
0.77
-0.77
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-17.06
-56.65
39.59
69.89%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-17.06
-56.65
39.59
69.89%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-17.06
-56.65
39.59
69.89%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
159.33
-199.18
358.51
179.99%
Earnings per share (EPS)
-0.36
-0.50
0.14
28.00%
Diluted Earnings per share
-0.36
-0.50
0.14
28.00%
Operating Profit Margin (Excl OI)
0.00%
-164.85%
0.00
164.85%
Gross Profit Margin
0.00%
-292.12%
0.00
292.12%
PAT Margin
0.00%
-300.68%
0.00
300.68%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
No Net Sales in the last few periods
Quarterly - Consolidate Net Profit
Consolidate Net Profit -1.71 Million
in Dec 2023Figures in Million
QoQ Growth in quarter ended Dec 2023 is 44.30% vs 3.76% in Sep 2023
YoY Growth in quarter ended Dec 2023 is 45.89% vs -20.61% in Dec 2022
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.89 Million
in Dec 2023Figures in Million
QoQ Growth in quarter ended Dec 2023 is 38.83% vs 8.85% in Sep 2023
YoY Growth in quarter ended Dec 2023 is 41.85% vs -24.05% in Dec 2022
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
No Operating Profit Margin (Excl OI) in the last few periods






